tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185

CanSino Biologics, Inc. Class H (6185) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CanSino Biologics, Inc. Class H
HK$44.94
HK$12.95B
-58.83
21.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$18.30
HK$44.30B
9.26
5.55%
0 Buy
0 Hold
0 Sell
Moderate Sell
Livzon Pharmaceutical Group
HK$30.94
HK$32.28B
11.23
10.39%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
HK$20.52
HK$74.79B
15.62
48.80%
3 Buy
1 Hold
1 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.57
HK$28.71B
9.44
-17.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Hansoh Pharmaceutical Group Company Limited
HK$37.42
HK$226.58B
43.11
112.61%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6185
CanSino Biologics, Inc. Class H
36.42
4.57
14.35%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
18.30
1.02
5.90%
HK:1513
Livzon Pharmaceutical Group
29.14
2.65
9.99%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
20.52
6.75
49.02%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.57
-0.89
-16.29%
HK:3692
Hansoh Pharmaceutical Group Company Limited
37.42
20.21
117.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts